Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
MeiraGTx Holdings PLC
MGTXCurrent price
6.64 USD
-0.52 USD (-7.26%)
Last closed
7.04 USD
Company
www.meiragtx.com
ISIN
KYG596651029
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
534 114 656 USD
Yield for 12 month
+34.14 %
1Y
3Y
5Y
10Y
15Y
MGTX
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York. Address: 450 East 29th Street, New York, NY, United States, 10016
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.6 USDP/E ratio
–Dividend Yield
–Current Year
+14 017 000 USD
Last Year
+15 920 000 USD
Current Quarter
+282 000 USD
Last Quarter
+697 000 USD
Current Year
+287 000 USD
Last Year
+7 197 000 USD
Current Quarter
-2 940 000 USD
Last Quarter
-2 578 000 USD
Key Figures MGTX
1 year
3 years
5 years
10 years
EBITDA
-155 308 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.66 %
PEG Ratio
–
Return On Equity TTM
-91.51 %
Wall Street Target Price
20.6 USD
Revenue TTM
8 122 000 USD
Book Value
1.24 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-92 %
Dividend Yield
–
Gross Profit TTM
15 920 000 USD
Earnings per share
-1.42 USD
Diluted Eps TTM
-1.42 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MGTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MGTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MGTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.5628
Enterprise Value Revenue
64.2336
Price Sales TTM
65.7615
Enterprise Value EBITDA
-3.2878
Price Book MRQ
6.6732
Financials MGTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MGTX
For 52 weeks
3.85 USD
7.6 USD
50 Day MA
4.85 USD
Shares Short Prior Month
1 934 907
200 Day MA
5.12 USD
Short Ratio
7.13
Shares Short
1 784 784
Short Percent
3.19 %
BeatStart